Which statement about topical corticosteroids in acute dermatitis is true?

Which statement about topical corticosteroids in acute dermatitis is true?

• A. The cream form is the most efficient system of delivery
• B. Short-term use of topical corticosteroids usually does not cause systemic adverse effects
• C. Apply creams and ointments with a glove in small amounts to prevent further infection
• D. Abruptly discontinuing the use of topical corticosteroids may cause a reappearance of dermatitis

Answer: (B)

When using topical corticosteroids for acute dermatitis, the key idea is that systemic adverse effects are unlikely with short-term, properly targeted use. These meds work mainly where they’re applied, and absorption into the bloodstream is limited unless certain risk factors are present. Short courses, applied to reasonable areas, with appropriate potency and non-occluded skin, result in minimal systemic exposure. That’s why the statement about short-term use usually not causing systemic adverse effects is the best fit. The risks of systemic effects rise with high-potency steroids, large treated areas, occlusive dressings, broken or inflamed skin, and use in young children. The other points are less universally true. The most efficient delivery method isn’t universally one form for all situations—the choice between creams, ointments, and other vehicles depends on the condition and the skin. Wearing a glove and using only small amounts isn’t a standard rule intended to prevent infection in this context. Abruptly stopping steroids can lead to withdrawal or rebound flares mainly after longer, not brief, courses of therapy.

When using topical corticosteroids for acute dermatitis, the key idea is that systemic adverse effects are unlikely with short-term, properly targeted use. These meds work mainly where they’re applied, and absorption into the bloodstream is limited unless certain risk factors are present.

Short courses, applied to reasonable areas, with appropriate potency and non-occluded skin, result in minimal systemic exposure. That’s why the statement about short-term use usually not causing systemic adverse effects is the best fit. The risks of systemic effects rise with high-potency steroids, large treated areas, occlusive dressings, broken or inflamed skin, and use in young children.

The other points are less universally true. The most efficient delivery method isn’t universally one form for all situations—the choice between creams, ointments, and other vehicles depends on the condition and the skin. Wearing a glove and using only small amounts isn’t a standard rule intended to prevent infection in this context. Abruptly stopping steroids can lead to withdrawal or rebound flares mainly after longer, not brief, courses of therapy.